Bristol-Myers Squibb
BMY
#166
Rank
A$179.35 B
Marketcap
A$88.10
Share price
3.94%
Change (1 day)
-5.02%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): A$4.61

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is A$4.23. In 2024 the company made an earnings per share (EPS) of A-$6.29 a decrease over its 2023 EPS that were of A$5.53.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$4.61-173.23%
2024A-$6.29-213.92%
2023A$5.5330.2%
2022A$4.24-6.04%
2021A$4.52-179.29%
2020A-$5.70-281.37%
2019A$3.14-27.21%
2018A$4.32
2016A$3.80175.26%
2015A$1.38-19.83%
2014A$1.72-22.44%
2013A$2.2234.48%
2012A$1.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$14.87 251.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.48 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$2.45-42.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$1.93-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$29.22 590.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$18.56 338.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$5.28 24.77%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$15.65 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.81 155.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$7.62 80.13%๐Ÿ‡ฌ๐Ÿ‡ง UK